Moxham Christopher
- SEC CIK
- 0001843784
No open-market purchases or sales filed in the past year.
Current role at each company
- FULC Fulcrum Therapeutics, Inc.Chief Scientific Officeras of Aug 12, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Moxham Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Moxham ChristopherChief Scientific Officer | SSale | −20.7K | $17.00 | −$352.1K | −100.0%0 after | |
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Moxham ChristopherChief Scientific Officer | SSaleCommon Stockm | −31.1K | $18.00 | −$559.3K | −100.0%0 after |